AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
32.26
-0.71 (-2.15%)
At close: Feb 18, 2026, 4:00 PM EST
32.10
-0.16 (-0.50%)
After-hours: Feb 18, 2026, 4:17 PM EST
AtriCure Stock Forecast
Stock Price Forecast
The 6 analysts that cover AtriCure stock have a consensus rating of "Strong Buy" and an average price target of $51.17, which forecasts a 58.62% increase in the stock price over the next year. The lowest target is $45 and the highest is $55.
Price Target: $51.17 (+58.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AtriCure stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 5 | 5 | 5 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $64 → $53 | Strong Buy | Maintains | $64 → $53 | +64.29% | Feb 18, 2026 |
| UBS | UBS | Strong Buy Maintains $60 → $55 | Strong Buy | Maintains | $60 → $55 | +70.49% | Feb 18, 2026 |
| Citizens | Citizens | Buy Maintains $60 → $52 | Buy | Maintains | $60 → $52 | +61.19% | Feb 18, 2026 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 18, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $54 | Strong Buy | Reiterates | $54 | +67.39% | Feb 18, 2026 |
Financial Forecast
Revenue This Year
614.15M
from 534.53M
Increased by 14.90%
Revenue Next Year
693.17M
from 614.15M
Increased by 12.87%
EPS This Year
-0.13
from -0.24
EPS Next Year
0.19
from -0.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 641.6M | 726.3M | |||
| Avg | 614.2M | 693.2M | |||
| Low | 578.2M | 656.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 20.0% | 18.3% | |||
| Avg | 14.9% | 12.9% | |||
| Low | 8.2% | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 0.39 | |||
| Avg | -0.13 | 0.19 | |||
| Low | -0.30 | -0.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.